ESSA Pharma Inc
NASDAQ:EPIX

Watchlist Manager
ESSA Pharma Inc Logo
ESSA Pharma Inc
NASDAQ:EPIX
Watchlist
Price: 1.67 USD -0.6%
Market Cap: 74.1m USD

FCF Margin
Free Cash Flow Margin

0%
Current
0%
Average
-7.1%
Industry

FCF Margin measures the amount of cash generated by a firm as a proportion of revenue. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

FCF Margin
0%
=
Free Cash Flow
-22.4m
/
Revenue
0

FCF Margin Across Competitors

ESSA Pharma Inc
Glance View

Market Cap
74.1m USD
Industry
Biotechnology

ESSA Pharma, Inc. is a clinical stage pharmaceutical company. The company is headquartered in Vancouver, British Columbia and currently employs 30 full-time employees. The firm is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The firm is evaluating EPI-7386 as a monotherapy for the treatment of adult male patients with metastatic castration-resistant prostate cancer (mCRPC) resistant to standard-of-care treatments.

EPIX Intrinsic Value
Not Available
What is Free Cash Flow Margin?

FCF Margin measures the amount of cash generated by a firm as a proportion of revenue. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

FCF Margin
0%
=
Free Cash Flow
-22.4m
/
Revenue
0
What is the FCF Margin of ESSA Pharma Inc?

Based on ESSA Pharma Inc's most recent financial statements, the company has FCF Margin of 0%.

Back to Top